Clinical

Dataset Information

0

Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer


ABSTRACT: This randomized phase III trial studies oxaliplatin, leucovorin calcium, fluorouracil, and bevacizumab to see how well they work compared to oxaliplatin, leucovorin calcium, and fluorouracil in treating patients who have undergone surgery for stage II colon cancer. Drugs used in chemotherapy, such as oxaliplatin, leucovorin calcium, and fluorouracil, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Monoclonal antibodies, such as bevacizumab, may interfere with the ability of tumor cells to grow and spread. It is not yet known whether giving combination chemotherapy together with bevacizumab is more effective than combination chemotherapy alone in treating colon cancer.

DISEASE(S): Colon Signet Ring Cell Adenocarcinoma,Adenocarcinoma,Colon, Unspecified,Carcinoma, Signet Ring Cell,Lynch Syndrome,Colon Mucinous Adenocarcinoma,Stage Iib Colon Cancer Ajcc V7,Colorectal Neoplasms, Hereditary Nonpolyposis,Stage Iic Colon Cancer Ajcc V7,Cystadenocarcinoma,Stage Ii Colon Cancer.,Stage Iia Colon Cancer Ajcc V7,Colon Cancer Stage Ii,Adenocarcinoma, Mucinous,Colonic Neoplasms

PROVIDER: 2020833 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2020-01-28 | GSE138912 | GEO
2015-12-31 | GSE69657 | GEO
| 2091141 | ecrin-mdr-crc
| 2159182 | ecrin-mdr-crc
2022-01-21 | GSE154524 | GEO
| 2255700 | ecrin-mdr-crc
2015-12-31 | E-GEOD-69657 | biostudies-arrayexpress
| 2182409 | ecrin-mdr-crc
| 2092221 | ecrin-mdr-crc
| 2316671 | ecrin-mdr-crc